Opmed.ai
PrivateLast Round
Series A
May 6, 2024
Total Funding Raised
$15.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Opmed.ai operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in May 2024.
Opmed.ai is a healthcare technology company that provides an AI-powered optimization platform designed to enhance operating room scheduling, resource allocation, and operational efficiency for hospitals.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Opmed.ai Comparables
Compare Opmed.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apella Technology | 88% | |
| Qventus | 83% | |
| Sifio Health | 79% |
For institutional investors. Book with your work email.
Opmed.ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 6, 2024 | ||||
| Pre Seed | Jun 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Opmed.ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Series A |
| Unbox Ventures | Series A, Pre Seed |
| Grove Ventures | Series A |
| Secret Chord Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 174% MoM, reaching 7.6K.
- Jul 1, 2026
Mass General Brigham disclosed as a customer.
For institutional investors. Book with your work email.
Opmed.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Opmed.ai's valuation, stock price, and market status.
Is Opmed.ai a public or private company?
Opmed.ai is a private company.
What is the current stock price of Opmed.ai?
Opmed.ai is a private company, so its shares have no public market price. Caplight tracks Opmed.ai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Opmed.ai worth (valuation)?
Valuation information for Opmed.ai is not publicly available.
Can I buy Opmed.ai stock?
Opmed.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Opmed.ai's last funding round?
Opmed.ai's most recent funding round was Series A on May 6, 2024.
Who are the main investors in Opmed.ai?
Key investors in Opmed.ai include NFX, Unbox Ventures, Grove Ventures.
Will Opmed.ai IPO soon?
No public IPO plans have been announced for Opmed.ai.
How can I track Opmed.ai secondary market activity?
Caplight tracks bids, offers, and trades in Opmed.ai's shares on secondary markets.